Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Apogent/Forefront

This article was originally published in The Gray Sheet

Executive Summary

Apogent Technologies' Applied Biotech division will consolidate production of Forefront Diagnostics' rapid drugs-of-abuse test kits into its San Diego rapid test manufacturing facility following acquisition of Forefront, announced Nov. 20. Forefront will add about $14 mil. to Apogent sales over the next 12 months. Portsmouth, New Hampshire-based Apogent, which makes clinical diagnostics, labware and life sciences equipment, generated sales in fiscal 2001 (ended Sept. 30) of $984.5 mil., up 14%...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel